Visentin A, Trentin L. Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”. haematol [Internet]. 2022Jun.1 [cited 2024Apr.25];107(6):1489-90. Available from: https://haematologica.org/article/view/haematol.2021.280199